Normal Structure and Function

The healthy vulvovaginal tissues undergo constant renewal and maintenance thanks to estrogen:

• Vaginal Epithelium: Multiple layers of estrogen-dependent cells rich in glycogen
• Vulvar Skin: Estrogen-maintained thickness and elasticity
• Vaginal Lubrication: Produced by vestibular glands and vaginal transudation
• Vaginal pH: Maintained at acidic 3.5-4.5 by lactobacilli
• Blood Supply: Rich vascular network maintained by estrogen

Changes with Estrogen Deficiency

With declining estrogen:

• Epithelial thickness decreases dramatically
• Glycogen stores deplete
• Lubrication decreases significantly
• pH rises (becomes less acidic)
• Blood flow diminishes
• Tissues become thin, pale, and fragile
• Loss of vaginal rugae (folds)
• Labia may shrink and fuse

Urethral and Bladder Changes

The urethra and bladder share estrogen receptors with genital tissues:

• Urethral epithelium thins
• Urethral closure pressure decreases
• Bladder mucosa becomes thinner
• Increased susceptibility to irritation
• Reduced ability to fight infection

Muscular Support

The pelvic floor muscles are also affected:

• Decreased muscle tone
• Reduced support for pelvic organs
• Potential for prolapse
• Urinary incontinence may worsen

Microbial Balance

Estrogen maintains healthy vaginal microbiome:

• Promotes lactobacillus dominance
• Maintains acidic pH
• Creates protective barrier
• Prevents overgrowth of pathogens

With estrogen decline:

• Lactobacillus decreases
• pH rises
• Pathogenic organisms may overgrow
• Increased infection risk

Mild GSM

• Minimal symptoms
• Slight tissue changes
• May be noticed only during intercourse
• Often responsive to simple treatments

Moderate GSM

• Multiple symptoms present
• Noticeable tissue changes
• Some urinary symptoms
• Requires more comprehensive treatment

Severe GSM

• Significant tissue atrophy
• Pain with minimal activity
• Prominent urinary symptoms
• May lead to complications
• Requires aggressive treatment

Gradual Onset (Most Common)

• Symptoms develop slowly over years
• Progressive if untreated
• Often not noticed initially
• Worsens with time since menopause

Acute Onset

• More common after surgical menopause
• Sudden hormonal withdrawal
• Symptoms more severe initially
• Requires prompt treatment

Predominantly Vaginal

• Primary symptoms are vaginal
• Dryness, atrophy, dyspareunia
• Less prominent urinary symptoms

Predominantly Urinary

• Urinary symptoms prominent
• Frequency, urgency, incontinence
• May be mistaken for other conditions

Mixed Presentation

• Both vaginal and urinary symptoms
• Most common presentation
• Comprehensive treatment needed

The fundamental cause of GSM is the significant decrease in estrogen production that occurs during menopause. This hormonal change affects virtually every tissue in the genitourinary tract.

Estrogen's Role in Genitourinary Health

Estrogen acts on tissues through estrogen receptors (both alpha and beta) found throughout the vulva, vagina, urethra, and bladder. Normal estrogen function includes:

• Maintaining epithelial thickness and integrity
• Supporting glycogen storage in vaginal cells
• Promoting healthy blood flow
• Stimulating lubrication production
• Maintaining muscle tone
• Supporting healthy microbiome
• Maintaining urethral closure pressure
• Promoting healthy pH

What Happens When Estrogen Declines

When ovarian estrogen production decreases:

• Epithelial tissues thin significantly
• Lubrication decreases substantially
• Blood flow diminishes
• Muscle tone decreases
• pH becomes less acidic
• Tissues become fragile and easily injured
• Urinary symptoms develop

Natural Menopause

• Gradual decline in ovarian function
• Typically begins in late 40s to early 50s
• Symptoms develop over months to years

Surgical Menopause

• Removal of ovaries causes abrupt estrogen loss
• Symptoms often severe and immediate
• May occur at any age

Premature Ovarian Insufficiency

• Ovarian function stops before age 40
• Similar symptoms to menopause
• Requires treatment to prevent complications

Cancer Treatments

• Chemotherapy may damage ovaries
• Radiation to pelvis affects tissues
• Some hormonal treatments for breast cancer

Age and Menopausal Status

• All postmenopausal women at risk
• Risk increases with time since menopause
• 50% of women within 5 years of menopause
• Up to 75% of women 5+ years after menopause

Surgical History

• Oophorectomy (ovarian removal)
• Radical hysterectomy
• Pelvic radiation therapy

Medication Factors

• Anti-estrogen medications
• Certain chemotherapy agents
• Some antidepressants
• Antihistamines

Lifestyle Factors

• Smoking (reduces blood flow)
• Sedentary lifestyle
• Poor nutrition

Protective Factors

• Hormone therapy
• Regular sexual activity
• Healthy lifestyle

Vulvovaginal Symptoms

• Vaginal dryness
• Burning or irritation
• Itching
• Pain during intercourse
• Bleeding after intercourse
• Tightness or narrowing
• Decreased lubrication

Urinary Symptoms

• Urinary urgency
• Frequency of urination
• Stress incontinence
• Urge incontinence
• Painful urination
• Recurrent urinary tract infections
• Post-void dribbling

Sexual Symptoms

• Decreased libido
• Reduced arousal
• Dyspareunia (pain)
• Decreased orgasm
• Loss of satisfaction

Vulvar Examination

• Thinning of vulvar skin
• Pale, smooth appearance
• Loss of labial fat
• Clitoral hood retraction
• Fusing of labia

Vaginal Examination

• Pale, smooth vaginal walls
• Loss of rugae (folds)
• Narrowing of vagina
• Fragile tissues
• Prolapse may be visible

Sexual Dysfunction

• Reduced sexual desire
• Arousal difficulties
• Orgasmic dysfunction
• Relationship impact

Urinary Complications

• Recurrent UTIs
• Incontinence
• Bladder pain

Quality of Life Impacts

• Reduced self-esteem
• Intimacy challenges
• Anxiety and depression
• Social withdrawal

Our comprehensive approach evaluates:

Medical History

• Menopausal history
• Symptoms and duration
• Previous treatments
• Impact on quality of life
• Sexual function concerns

Lifestyle Assessment

• Diet and nutrition
• Exercise habits
• Stress levels
• Sleep quality

Physical Examination

• Vulvar inspection
• Vaginal examination
• Pelvic floor assessment
• Urinary symptom evaluation

Clinical Diagnosis Based primarily on:

• Characteristic symptoms
• Physical findings
• Temporal relationship to menopause

Supporting Tests

• Vaginal pH testing
• Vaginal cytology
• Urinalysis if urinary symptoms
• Hormone testing if needed

Infections

• Yeast infections
• Bacterial vaginosis
• STIs
• Urinary tract infections

Inflammatory Conditions

• Lichen sclerosus
• Lichen planus
• Contact dermatitis

Other Conditions

• Endometriosis
• Pelvic organ prolapse
• Interstitial cystitis

Local Estrogen Therapy

• Vaginal creams
• Vaginal tablets
• Vaginal rings
• Lower risk than systemic therapy

Systemic Hormone Therapy

• Oral estrogen
• Transdermal estrogen
• Combined therapy
• Benefits multiple symptoms

Non-Hormonal Options

• Vaginal moisturizers
• Lubricants
• Ospemifene (selective estrogen receptor modulator)

At Healers Clinic, we provide comprehensive integrative care:

Constitutional Homeopathy

• Individualized remedy selection
• Addresses whole person
• Supports overall wellbeing

Ayurvedic Medicine

• Balance Vata and Pitta
• Herbal support
• Dietary recommendations

Integrative Nutrition

• Phytoestrogen-rich foods
• Anti-inflammatory diet
• Key nutrients for tissue health

Pelvic Floor Physiotherapy

• Strengthening exercises
• Manual therapy
• Biofeedback

Bioidentical Hormone Therapy

• Individualized formulations
• Comprehensive testing
• Regular monitoring

Sexual Health

• Regular activity promotes blood flow
• Use lubricants generously
• Extended foreplay

Hygiene

• Gentle products
• Cotton underwear
• Avoid irritants

Diet

• Phytoestrogen foods
• Omega-3 fatty acids
• Hydration

• Maintain healthy lifestyle
• Don't smoke
• Regular exercise
• Healthy diet
• Address symptoms early
• Consider preventive hormone therapy

Most women experience significant improvement with appropriate treatment. Early intervention leads to better outcomes. Treatment is typically long-term as GSM is usually a chronic condition.

GSM is the comprehensive term that includes vaginal atrophy plus urinary symptoms and sexual changes. Vaginal atrophy is just one component of GSM. The term GSM was adopted to better describe the full spectrum of changes and encourage more women to seek treatment.

GSM cannot be cured as it results from permanent hormonal changes. However, symptoms can be effectively managed with treatment. Ongoing therapy is typically needed to maintain results.

While GSM is most common in postmenopausal women, it can affect younger women who have undergone surgical menopause or certain cancer treatments. Some women experience symptoms during perimenopause as estrogen begins to decline.

Regular sexual activity can actually help by promoting blood flow to vaginal tissues. However, without adequate lubrication, it can cause irritation and pain. Using lubricants and allowing sufficient time for arousal is important.

Some improvement may be noticed within weeks, but full benefits may take 2-3 months. Ongoing treatment is needed to maintain results as GSM is typically chronic.

Low-dose vaginal estrogen typically has minimal systemic absorption and is considered safe for most women. However, individual assessment is important. Our practitioners will discuss benefits and risks with you.

We offer truly integrative care combining conventional and complementary approaches. Our team includes homeopaths, Ayurvedic practitioners, nutritionists, physiotherapists, and hormone therapy specialists working together to address your unique needs.

Call +971 56 274 1787 or visit https://healers.clinic/booking/